NUNZ — Nunzia Pharmaceutical Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2016 December 31st | 2017 December 31st | 2018 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0 | 0.013 | 0.027 | 9.04 | 78.1 |
Operating Profit | 0 | -0.013 | -0.027 | -9.04 | -78.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0 | -0.013 | -0.019 | -101 | -78.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0 | -0.013 | -0.019 | -101 | -78.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 0 | -0.013 | -0.019 | -101 | -78.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0 | -0.013 | -0.019 | -101 | -78.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | -0.634 | -0.903 | -0.323 | -0.256 |